Not all high dividend yields are safe. In fact, some of the shares on our list have a conservative dividend yield but a solid dividend cover ratio – a metric that helps determine dividend sustainability. This list highlights five ASX shares backed by strong dividend cover ratios above 1.5x. Use it to spot real income opportunities and avoid dangerous yield traps.
This article is for informational purposes only and does not constitute investment or trading advice. Please ensure you understand the risks and consider your individual circumstances before trading.
ASX dividend stocks are shares in Australian companies that pay part of their profits back to shareholders as cash or additional shares. For many traders, they’re a way to earn regular income without selling their investments.
When you’re picking dividend stocks, there are three key things to check:
If you keep these three points in mind, you can filter out weaker candidates before you invest.
A ‘dividend trap’ happens when a stock’s yield looks unusually high because the share price has dropped, often due to problems in the business. New investors sometimes buy in for the income, only to see the dividend cut and the share price fall further.
To reduce the risk of falling into a trap:
In short: a high yield on paper doesn’t mean it’s a safe income stream. A balanced approach that combines reliable dividend payers with some higher-yield opportunities can help smooth out risk.
From AFT Pharmaceuticals’ 0.67% dividend yield to Medibank Private’s 3.81%, these five shares offer dividend income, backed by solid fundamentals.
Each of the stocks in this article can be share traded and CFD traded with IG Australia.
All figures are accurate as of 22 May 2026.
Company |
Market cap |
Dividend yield |
Dividend cover ratio |
Trade the share CFD with us? |
Share trade the stock with us? |
A$300.27 billion1 |
3.31%2 |
~2.05x |
✓ |
✓ |
|
A$8.39 billion3 |
2.84%4 |
~3.12x |
✓ |
✓ |
|
A$13.36 billion5 |
3.81%6 |
~1.50x |
✓ |
✓ |
|
A$6.34 billion7 |
3.23%8 |
~2.20x |
✓ |
✓ |
|
A$327.53 million9 |
0.67%10 |
~6.00x |
✓ |
✓ |
Sector: Non-energy minerals
Market cap: A$300.27 billion
Dividend yield: 3.31%
Dividend cover ratio: ~2.05x
BHP is a global resources company and one of the largest miners in the world. It focuses on discovering, acquiring and marketing diverse natural commodities. Its primary operations revolve around iron ore, copper and metallurgical coal, which are foundational materials for global infrastructure and steelmaking. It also maintains expanding interests in potash to support the agricultural sector.
Over the past six months, BHP has navigated an environment shaped by changing global growth dynamics and infrastructure demand. The business has focused heavily on expanding its copper pipelines, actively positioning itself to benefit from long-term global electrification trends. It has also managed operational headwinds caused by severe weather disruptions impacting regional shipping logistics, alongside shifting global supply chains that have caused minor price fluctuations across its core iron ore portfolio.
BHP is attractive to share traders looking for large-cap stability with a history of robust dividend generation. Because it operates with world-class, low-cost extraction assets, it frequently generates massive free cash flows when commodity pricing is strong. This cash generation allows it to offer high, fully franked dividend yields, making it an excellent anchor stock for income-focused portfolios.
Risks:
Sector: Energy minerals
Market cap: A$8.39 billion
Dividend yield: 2.84%
Dividend cover ratio: ~3.12x
Ampol is a transport fuel provider and convenience retailer in Australia and New Zealand. The company manages a massive, fully integrated supply chain that spans international fuel sourcing, product distribution and the iconic Lytton oil refinery in Queensland.
Alongside its wholesale fuel operations, Ampol operates an expansive retail network of service stations under the Foodary brand.
The last six months have been dynamic for Ampol, characterised by geopolitical tensions in energy markets and extreme domestic weather events, including disruptions from Cyclone Alfred. Despite these disruptions, the company managed to post improved group earnings.
For share traders, Ampol offers a unique hybrid of defensive retail cash flows mixed with cyclical energy exposure. Its retail convenience stores provide steady revenue regardless of the broader economic backdrop, while its refining operations capture strong margins during periods of tight global fuel supply.
Risks:
Sector: Finance
Market cap: A$13.36 billion
Dividend yield: 3.81%
Dividend cover ratio: ~1.50x
Medibank Private is a dominant player in the Australian health insurance market, providing private health cover to millions of customers through its Medibank and Australian Health Management (AHM) brands.
Beyond standard insurance policies, the company increasingly operates as a broader healthcare provider, investing in virtual care models, short-stay hospitals and digital wellbeing initiatives to reduce structural pressure on public healthcare systems.
Over the last half-year, Medibank has reported steady customer growth, driven by a growing public appreciation for flexible health support.
Medibank appeals to share traders who value defensive earnings and predictable, non-cyclical cash flows. Because health insurance is viewed as an essential expense by many consumers, its earnings remain remarkably resilient during general economic downturns. This structural stability supports a consistent dividend payout ratio, making it a potentially reliable choice for maintaining cash flow within a portfolio.
Risks:
Sector: Finance
Market cap: A$6.34 billion
Dividend yield: 3.23%
Dividend cover ratio: ~2.20x
Challenger is an investment management company that is one of Australia’s largest providers of annuities and retirement income products. The company specialises in converting retiree savings into guaranteed, predictable income streams.
It operates through two primary segments: a Life division that manufactures structured financial products, and a Funds Management business that handles a vast array of global assets.
The company continues to benefit from its strategic relationship with international insurance giants like Dai-Ichi Life, which maintains a substantial ownership stake in the business.
Challenger is perfectly positioned to capture a structural macroeconomic tailwind: Australia’s rapidly aging population and the massive pool of wealth moving into the retirement phase. Share traders often favour the stock because its core annuity products become more attractive to conservative investors during periods of higher interest rates, allowing the business to expand its profit margins and maintain healthy dividends.
Risks:
Sector: Health technology
Market cap: A$327.53 million
Dividend yield: 0.67%
Dividend cover ratio: ~6.00x
AFT Pharmaceuticals is a growing pharmaceutical company that develops, licenses and distributes a wide range of health products globally. It operates across over-the-counter, prescription and hospital channels. The company is best known for its patented pain relief formulation, Maxigesic, which it has successfully commercialised in major international markets alongside a growing portfolio of skin, eye and liposomal wellness treatments.
The company has aggressively expanded its international business hubs, broadening the distribution of its key pain relief products across independent pharmacy networks in the UK and launching new medical formulations in Canada.
AFT Pharmaceuticals is suited for share traders looking for a mixture of healthcare defensiveness and global growth upside. Unlike static insurers or utilities, AFT generates growing royalty streams and licensing income as its products enter new international jurisdictions.
Risks:
ASX dividend stocks are shares of companies listed on the Australian Securities Exchange (ASX) that pay part of their profits to shareholders, usually as cash payments. They can provide regular income in addition to potential share price growth.
Most ASX-listed companies pay dividends twice a year: an interim dividend and a final dividend. Some pay quarterly, while others may pay only once a year. The schedule depends on the company’s financial calendar.
A yield between 2% and 6% is considered healthy for many established Australian companies; however, this isn’t a hard-and-fast rule. Higher yields can be attractive but may also signal higher risk, so it’s important to check the company’s financial health and dividend sustainability.
Avoiding a dividend trap means looking beyond yield. Check the company’s earnings trend, debt levels and history of paying dividends. A high yield caused by a falling share price may be a warning sign rather than a bargain.
Yes. Many ASX companies offer a Dividend Reinvestment Plan (DRP), which lets you automatically use your dividend payments to buy more shares instead of taking cash. This can compound returns over time.
Yes. Through brokers like IG Australia, international investors can trade ASX-listed dividend stocks or via derivatives such as CFDs. Availability may depend on your local regulations.
This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.